BB Biotech AG (BION.SW) — Technical state
As of 2026-10-30 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.
The Closelooknet read
- Closelooknet score: 74 out of 100 (momentum 71 · quality 96 · valuation 81), as of 2026-11-01.
- Signal: Pullback inside an uptrend stack — Trades -1% vs the 50-day and +7.7% vs the 200-day average, 10% below the 52-week high and +34.8% off the 52-week low. Computed from daily closes. (as of 2026-10-30)
- Trend: BB Biotech AG trades 1.0% below its 50-day and 7.7% above its 200-day moving average. (as of 2026-10-30)
BB Biotech AG is a closed-end investment company that holds a global portfolio of biotechnology equities, chosen through fundamental research rather than an index. It is managed by Bellevue Asset Management and is domiciled in Switzerland, giving investors exposure to the sector rather than to any single drug or therapy.
The full read — the desk's view, the earnings record, peers and the company snapshot — is on the BION.SW overview. Agents can buy the score depth per call over HTTP 402 — see the catalogue. Research diary readings, not advice.
Trades -1% vs the 50-day and +7.7% vs the 200-day average, 10% below the 52-week high and +34.8% off the 52-week low. Computed from daily closes.
The moving-average stack
- vs 20-day+3.5%
- vs 50-day-1%
- vs 200-day+7.7%
- 52-week band10% off the high · +34.8% off the low
- Streak2 consecutive up sessions
- 50-day crossprice crossed down through the 50-day 35 sessions ago
- Stochastic%K 81.4 · %D 85 · bear cross
Continue: the BION.SW chart & overview · quality & forensics · the signal board
FAQ · from the current data · as of 2026-10-30
Quick answers
What is the current Closelooknet signal on BION.SW?
Pullback inside an uptrend stack — Trades -1% vs the 50-day and +7.7% vs the 200-day average, 10% below the 52-week high and +34.8% off the 52-week low. Computed from daily closes. As of 2026-10-30; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.
Is BION.SW above its 50-day and 200-day moving averages?
As of 2026-10-30, BB Biotech AG trades -1% below its 50-day and +7.7% above its 200-day average, with the 20-day +3.5% away.
How far is BION.SW from its 52-week high?
10% below the 52-week high and 34.8% above the 52-week low, as of 2026-10-30.
Related in the Closelooknet universe
then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- HALO Halozyme Therapeutics Incindustry
- ONC BeiGene, Ltd.industry
- UCB.BR UCB SAindustry
- ARGX.BR Argen-Xindustry
- ARGX argenx NV ADRindustry
- KRYS Krystal Biotech Incindustry
- KOD Kodiak Sciences Incindustry
- REPL Replimune Group Incindustry
- MRNA Moderna Incindustry
- ARQT Arcutis Biotherapeutics Incindustry
- DNA Ginkgo Bioworks Holdingsindustry
- ABSI Absci Corpindustry
- EXEL Exelixis Incindustry
- ONT.L Oxford Nanopore Technologies Ltdindustry
- XNCR Xencor Incindustry
- ALK-B.CO ALK-Abelló A/Sindustry
- ADMA ADMA Biologics Incindustry
- VRDN Viridian Therapeutics Incindustry
- IRON Disc Medicine Inc.industry
- BHVN Biohaven Ltd.industry